latest news in Oncology Drugs

Eli Lilly Drug Earns Fast-Track FDA Status for Pancreatic Cancer

Indianapolis, Tuesday, 4 August 2026.
Eli Lilly received FDA Breakthrough Therapy designation for olomorasib to treat advanced pancreatic cancer. This marks the drug’s second fast-track status, addressing a fatal condition with no current approved targeted options.

Chinese Regulators Fast-Track Promising Two-Drug Combination for Blood Cancer Treatment

Beijing, Tuesday, 4 August 2026.
China fast-tracked InnoCare’s dual-drug therapy for blood cancer after clinical trials demonstrated a 100% response rate, significantly accelerating the approval process for this innovative treatment.